SCHEMBL26164167

SCHEMBL26164167

Cc1cccc(-c2ccccc2-c2cccc([N+](=O)[O-])c2F)c1-c1ccccc1N

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B10 Q99714 1/20 0.46
TSHR P16473 2/20 0.44
SMN1; SMN2 Q16637 2/20 0.44
LMNA P02545 1/20 0.43
MGAM O43451 2/20 0.42
GAA P10253 2/20 0.42
SI P14410 2/20 0.42
MGAM2 Q2M2H8 2/20 0.42
TDP1 Q9NUW8 5/20 0.40
S100A4 P26447 2/20 0.40
PTPRC P08575 1/20 0.40
L3MBTL1 Q9Y468 2/20 0.39
PDE7A Q13946 1/20 0.39
ALDH1A1 P00352 4/20 0.37
MAPT P10636 2/20 0.37
KMT2A Q03164 2/20 0.37
MEN1 O00255 1/20 0.37
HPGD P15428 1/20 0.37
HSP90AA1 P07900 1/20 0.36
CDK5 Q00535 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31713028 0.87 S100A4 (0.45) HSD17B10SMN1; SMN2MGAMGAASI
SCHEMBL29565972 0.87 PDE7A (0.46) HSD17B10SMN1; SMN2MGAMGAASI
SCHEMBL26164138 0.87 PDE7A (0.46) HSD17B10SMN1; SMN2MGAMGAASI
SCHEMBL26167519 0.85 ALDH1A1 (0.49) SMN1; SMN2LMNATDP1S100A4PTPRC
SCHEMBL26164174 0.85 ALDH1A1 (0.47) HSD17B10TSHRSMN1; SMN2LMNAMGAM
SCHEMBL29565823 0.85 ALDH1A1 (0.49) SMN1; SMN2LMNATDP1S100A4PTPRC
SCHEMBL10711629 0.84 HSD17B10 (0.56) HSD17B10TSHRSMN1; SMN2LMNAMGAM
SCHEMBL26164166 0.79 HSD17B10 (0.50) HSD17B10TSHRSMN1; SMN2LMNAMGAM
SCHEMBL11901648 0.77 S100A4 (0.50) SMN1; SMN2LMNAMGAMGAASI
SCHEMBL11617176 0.76 TDP1 (0.57) HSD17B10MGAMGAASIMGAM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230167145-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION (US) 2023-06-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230167145-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES OCIAD1, OCIAD2, OSBP HSD17B10 1595/4885TSHR 3056/4885SMN1; SMN2 4063/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.